Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Odermatt

Showing results (51-60 of 220) with videos related to

Pageof 22
Sort By:
Toxicology and Applied Pharmacology|April 30, 2024
In silico and in vitro assessment of drugs potentially causing adverse effects by inhibiting CYP17A1Jacek Kędzierski, Marie-Christin Jäger, Sadaf Naeem, et al.
The Journal of Biological Chemistry|May 21, 2004
Appropriate function of 11beta-hydroxysteroid dehydrogenase type 1 in the endoplasmic reticulum lumen is dependent on its N-terminal region sharing similar topological determinants with 50-kDa esteraseChristoph Frick, Atanas G Atanasov, Peter Arnold, et al.
Toxicology and Applied Pharmacology|January 2, 2021
Species-specific differences in the inhibition of 11β-hydroxysteroid dehydrogenase 2 by itraconazole and posaconazoleSilvia G Inderbinen, Michael Zogg, Manuel Kley, et al.
Molecular and Cellular Endocrinology|June 26, 2020
Protein phosphatase 1 alpha enhances glucocorticoid receptor activity by a mechanism involving phosphorylation of serine-211Melanie Patt, Joël Gysi, Nourdine Faresse, et al.
Molecular and Cellular Endocrinology|December 5, 2003
A rapid screening assay for inhibitors of 11beta-hydroxysteroid dehydrogenases (11beta-HSD): flavanone selectively inhibits 11beta-HSD1 reductase activityRoberto A S Schweizer, Atanas G Atanasov, Brigitte M Frey, et al.
Talanta|January 11, 2019
Removal of batch effects using stratified subsampling of metabolomic data for in vitro endocrine disruptors screeningJulien Boccard, David Tonoli, Petra Strajhar, et al.
Molecular and Cellular Endocrinology|November 18, 2008
Hexose-6-phosphate dehydrogenase modulates the effect of inhibitors and alternative substrates of 11beta-hydroxysteroid dehydrogenase 1Zoltán Balázs, Lyubomir G Nashev, Charlie Chandsawangbhuwana, et al.
American Journal of Physiology. Renal Physiology|March 9, 2023
A novel mouse model for an inducible gene modification in the renal thick ascending limbLaurent Bourqui, Denise V Winter, Alex Odermatt, et al.
The Journal of Biological Chemistry|February 20, 2004
Rapid hepatic metabolism of 7-ketocholesterol by 11beta-hydroxysteroid dehydrogenase type 1: species-specific differences between the rat, human, and hamster enzymeRoberto A S Schweizer, Marcel Zürcher, Zoltan Balazs, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 25, 2016
Role of Pro-637 and Gln-642 in human glucocorticoid receptors and Ser-843 and Leu-848 in mineralocorticoid receptors in their differential responses to cortisol and aldosteroneOrlando Mani, Lyubomir G Nashev, Christopher Livelo, et al.
Pageof 22

Showing results (51-60 of 220) with videos related to

Sort By:
Pageof 22
Toxicology and Applied Pharmacology|April 30, 2024
In silico and in vitro assessment of drugs potentially causing adverse effects by inhibiting CYP17A1Jacek Kędzierski, Marie-Christin Jäger, Sadaf Naeem, et al.
The Journal of Biological Chemistry|May 21, 2004
Appropriate function of 11beta-hydroxysteroid dehydrogenase type 1 in the endoplasmic reticulum lumen is dependent on its N-terminal region sharing similar topological determinants with 50-kDa esteraseChristoph Frick, Atanas G Atanasov, Peter Arnold, et al.
Toxicology and Applied Pharmacology|January 2, 2021
Species-specific differences in the inhibition of 11β-hydroxysteroid dehydrogenase 2 by itraconazole and posaconazoleSilvia G Inderbinen, Michael Zogg, Manuel Kley, et al.
Molecular and Cellular Endocrinology|June 26, 2020
Protein phosphatase 1 alpha enhances glucocorticoid receptor activity by a mechanism involving phosphorylation of serine-211Melanie Patt, Joël Gysi, Nourdine Faresse, et al.
Molecular and Cellular Endocrinology|December 5, 2003
A rapid screening assay for inhibitors of 11beta-hydroxysteroid dehydrogenases (11beta-HSD): flavanone selectively inhibits 11beta-HSD1 reductase activityRoberto A S Schweizer, Atanas G Atanasov, Brigitte M Frey, et al.
Talanta|January 11, 2019
Removal of batch effects using stratified subsampling of metabolomic data for in vitro endocrine disruptors screeningJulien Boccard, David Tonoli, Petra Strajhar, et al.
Molecular and Cellular Endocrinology|November 18, 2008
Hexose-6-phosphate dehydrogenase modulates the effect of inhibitors and alternative substrates of 11beta-hydroxysteroid dehydrogenase 1Zoltán Balázs, Lyubomir G Nashev, Charlie Chandsawangbhuwana, et al.
American Journal of Physiology. Renal Physiology|March 9, 2023
A novel mouse model for an inducible gene modification in the renal thick ascending limbLaurent Bourqui, Denise V Winter, Alex Odermatt, et al.
The Journal of Biological Chemistry|February 20, 2004
Rapid hepatic metabolism of 7-ketocholesterol by 11beta-hydroxysteroid dehydrogenase type 1: species-specific differences between the rat, human, and hamster enzymeRoberto A S Schweizer, Marcel Zürcher, Zoltan Balazs, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 25, 2016
Role of Pro-637 and Gln-642 in human glucocorticoid receptors and Ser-843 and Leu-848 in mineralocorticoid receptors in their differential responses to cortisol and aldosteroneOrlando Mani, Lyubomir G Nashev, Christopher Livelo, et al.
Pageof 22